Your browser doesn't support javascript.
loading
Atrial fibrillation considerations in the fourth trimester (postpartum period).
Li, Shuo; Girgla, Saavia; Sherman, Andrew; Alpay-Savasan, Zeynep; Mehta, Nishaki.
Afiliação
  • Li S; Internal Medicine Residency, Beaumont Hospital Royal Oak, Royal Oak, MI, USA.
  • Girgla S; Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak, Royal Oak, MI, USA.
  • Sherman A; Internal Medicine Residency, Beaumont Hospital Royal Oak, Royal Oak, MI, USA.
  • Alpay-Savasan Z; Division of Maternal and Fetal Medicine, Beaumont Hospital Royal Oak, Royal Oak, MI, USA.
  • Mehta N; Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak, Royal Oak, MI, USA. nishaki.mehta@corewellhealth.org.
J Interv Card Electrophysiol ; 67(4): 901-914, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38363430
ABSTRACT
Postpartum atrial fibrillation is an uncommon but increasingly prevalent tachyarrhythmia that merits special management considerations with regards to the safety and efficacy of anticoagulation, rate and rhythm control as well as drug exposure to infants throughout breastfeeding. In this state-of-the-art review, we examine the demographics of postpartum atrial fibrillation with its associated risk factors, describe the safety of commonly used atrial fibrillation therapies, and discuss important considerations for women considering subsequent pregnancies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article